Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population

E Sverre, K Peersen, H Weedon-Fekjær, J Perk, E Gjertsen, E Husebye, L Gullestad, T Dammen, J E Otterstad, J Munkhaugen, E Sverre, K Peersen, H Weedon-Fekjær, J Perk, E Gjertsen, E Husebye, L Gullestad, T Dammen, J E Otterstad, J Munkhaugen

Abstract

Background: The relative importance of lifestyle, medical and psychosocial factors on the risk of recurrent major cardiovascular (CV) events (MACE) in coronary patients' needs to be identified. The main objective of this study is to estimate the association between potentially preventable factors on MACE in an outpatient coronary population from routine clinical practice.

Methods: This prospective follow-up study of recurrent MACE, determine the predictive impact of risk factors and a wide range of relevant co-factors recorded at baseline. The baseline study included 1127 consecutive patients 2-36 months after myocardial infarction (MI) and/or revascularization procedure. The primary composite endpoint of recurrent MACE defined as CV death, hospitalization due to MI, revascularization, stroke/transitory ischemic attacks or heart failure was obtained from hospital records. Data were analysed using cox proportional hazard regression, stratified by prior coronary events before the index event.

Results: During a mean follow-up of 4.2 years from study inclusion (mean time from index event to end of study 5.7 years), 364 MACE occurred in 240 patients (21, 95% confidence interval: 19 to 24%), of which 39 were CV deaths. In multi-adjusted analyses, the strongest predictor of MACE was not taking statins (Relative risk [RR] 2.13), succeeded by physical inactivity (RR 1.73), peripheral artery disease (RR 1.73), chronic kidney failure (RR 1.52), former smoking (RR 1.46) and higher Hospital Anxiety and Depression Scale-Depression subscale score (RR 1.04 per unit increase). Preventable and potentially modifiable factors addressed accounted for 66% (95% confidence interval: 49 to 77%) of the risk for recurrent events. The major contributions were smoking, low physical activity, not taking statins, not participating in cardiac rehabilitation and diabetes.

Conclusions: Coronary patients were at high risk of recurrent MACE. Potentially preventable clinical and psychosocial factors predicted two out of three MACE, which is why these factors should be targeted in coronary populations.

Trial registration: Registered at ClinicalTrials.gov: NCT02309255. Registered at December 5th, 2014, registered retrospectively.

Keywords: Coronary heart disease; Prognosis; Psychosocial factors; Recurrent cardiovascular events; Risk factors; Secondary prevention.

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Fig. 1
Fig. 1
Study flow chart

References

    1. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur J Prev Cardiol. 2016;23(11):Np1–np96. doi: 10.1177/2047487316653709.
    1. Kotseva Kornelia, De Backer Guy, De Bacquer Dirk, Rydén Lars, Hoes Arno, Grobbee Diederick, Maggioni Aldo, Marques-Vidal Pedro, Jennings Catriona, Abreu Ana, Aguiar Carlos, Badariene Jolita, Bruthans Jan, Castro Conde Almudena, Cifkova Renata, Crowley Jim, Davletov Kairat, Deckers Jaap, De Smedt Delphine, De Sutter Johan, Dilic Mirza, Dolzhenko Marina, Dzerve Vilnis, Erglis Andrejs, Fras Zlatko, Gaita Dan, Gotcheva Nina, Heuschmann Peter, Hasan-Ali Hosam, Jankowski Piotr, Lalic Nebojsa, Lehto Seppo, Lovic Dragan, Mancas Silvia, Mellbin Linda, Milicic Davor, Mirrakhimov Erkin, Oganov Rafael, Pogosova Nana, Reiner Zeljko, Stöerk Stefan, Tokgözoğlu Lâle, Tsioufis Costas, Vulic Dusko, Wood David. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. European Journal of Preventive Cardiology. 2019;26(8):824–835. doi: 10.1177/2047487318825350.
    1. Santos Raul D. Inadequate control of atherosclerotic cardiovascular disease risk factors in Europe: EUROASPIRE repeats itself. European Journal of Preventive Cardiology. 2019;26(8):820–823. doi: 10.1177/2047487319831476.
    1. Ek A, Ekblom O, Hambraeus K, Cider A, Kallings LV, Borjesson M. Physical inactivity and smoking after myocardial infarction as predictors for readmission and survival: results from the SWEDEHEART-registry. Clin Res Cardiol. 2019;108(3):324–332. doi: 10.1007/s00392-018-1360-x.
    1. Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM, Wilson PW, Alberts MJ, D'Agostino R, Liau CS, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010;304(12):1350–1357. doi: 10.1001/jama.2010.1322.
    1. Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J. 2015;36(19):1163–1170. doi: 10.1093/eurheartj/ehu505.
    1. De Bacquer D, De Smedt D, Kotseva K, Jennings C, Wood D, Ryden L, Gyberg V, Shahim B, Amouyel P, Bruthans J, et al. Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study. Eur J Epidemiol. 2019;34(3):247–258. doi: 10.1007/s10654-018-0454-0.
    1. Munkhaugen John, Sverre Elise, Peersen Kari, Gjertsen Erik, Gullestad Lars, Moum Torbjorn, Erik Otterstad Jan, Perk Joep, Husebye Einar, Dammen Toril. The role of medical and psychosocial factors for unfavourable coronary risk factor control. Scandinavian Cardiovascular Journal. 2015;50(1):1–8. doi: 10.3109/14017431.2015.1111408.
    1. Accessed 25 Nov 2015 at and .
    1. Accessed 1 Nov 2016 at ,
    1. Peersen K, Munkhaugen J, Gullestad L, Liodden T, Moum T, Dammen T, Perk J, Otterstad JE. The role of cardiac rehabilitation in secondary prevention after coronary events. Eur J Prev Cardiol. 2017;24(13):1360–1368. doi: 10.1177/2047487317719355.
    1. Burns EM, Rigby E, Mamidanna R, Bottle A, Aylin P, Ziprin P, Faiz OD. Systematic review of discharge coding accuracy. J Public Health (Oxford, England) 2012;34(1):138–148. doi: 10.1093/pubmed/fdr054.
    1. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087–1091. doi: 10.1016/j.jclinepi.2006.01.014.
    1. Breitling LP. Current genetics and epigenetics of smoking/tobacco-related cardiovascular disease. Arterioscler Thromb Vasc Biol. 2013;33(7):1468–1472. doi: 10.1161/ATVBAHA.112.300157.
    1. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev. 2004;1:CD003041. 10.1002/14651858.CD003041.pub2.
    1. Moholdt T, Lavie CJ, Nauman J. Sustained physical activity, not weight loss, associated with improved survival in coronary heart disease. J Am Coll Cardiol. 2018;71(10):1094–1101. doi: 10.1016/j.jacc.2018.01.011.
    1. Stewart RAH, Held C, Hadziosmanovic N, Armstrong PW, Cannon CP, Granger CB, Hagstrom E, Hochman JS, Koenig W, Lonn E, et al. Physical activity and mortality in patients with stable coronary heart disease. J Am Coll Cardiol. 2017;70(14):1689–1700. doi: 10.1016/j.jacc.2017.08.017.
    1. Lahtinen M, Toukola T, Junttila MJ, Piira OP, Lepojarvi S, Kaariainen M, Huikuri HV, Tulppo MP, Kiviniemi AM. Effect of changes in physical activity on risk for cardiac death in patients with coronary artery disease. Am J Cardiol. 2018;121(2):143–148. doi: 10.1016/j.amjcard.2017.10.002.
    1. van Halewijn G, Deckers J, Tay HY, van Domburg R, Kotseva K, Wood D. Lessons from contemporary trials of cardiovascular prevention and rehabilitation: a systematic review and meta-analysis. Int J Cardiol. 2017;232:294–303. doi: 10.1016/j.ijcard.2016.12.125.
    1. Olsen SJ, Schirmer H, Bonaa KH, Hanssen TA. Cardiac rehabilitation after percutaneous coronary intervention: results from a nationwide survey. Eur J Cardiovasc Nurs. 2018;17(3):273–279. doi: 10.1177/1474515117737766.
    1. Rutledge T, Redwine LS, Linke SE, Mills PJ. A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med. 2013;75(4):335–349. doi: 10.1097/PSY.0b013e318291d798.
    1. Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, Bliden K, Tantry U, Kubica J, Raggi P, Gurbel PA. Association between baseline LDL-C level and Total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis. Jama. 2018;319(15):1566–1579. doi: 10.1001/jama.2018.2525.
    1. Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, Roden M, Stein E, Tokgozoglu L, Nordestgaard BG, et al. Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, Aetiology and Management. Eur Heart J. 2015;36(17):1012–1022. doi: 10.1093/eurheartj/ehv043.
    1. Hastie CE, Padmanabhan S, Slack R, Pell AC, Oldroyd KG, Flapan AD, Jennings KP, Irving J, Eteiba H, Dominiczak AF, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J. 2010;31(2):222–226. doi: 10.1093/eurheartj/ehp317.
    1. Pedersen SS, von Kanel R, Tully PJ, Denollet J. Psychosocial perspectives in cardiovascular disease. Eur J Prev Cardiol. 2017;24(3_suppl):108–115. doi: 10.1177/2047487317703827.
    1. Richards SH, Anderson L, Jenkinson CE, Whalley B, Rees K, Davies P, Bennett P, Liu Z, West R, Thompson DR, et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev. 2017;4:CD002902. doi: 10.1002/14651858.CD002902.pub4.
    1. Pogosova N, Saner H, Pedersen SS, Cupples ME, McGee H, Hofer S, Doyle F, Schmid JP, von Kanel R. Psychosocial aspects in cardiac rehabilitation: from theory to practice. A position paper from the cardiac rehabilitation section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol. 2015;22(10):1290–1306. doi: 10.1177/2047487314543075.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe